Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Laser System Improves Lipolysis Procedure

By HospiMedica staff writers
Posted on 05 Dec 2006
A new laser system offers a minimally invasive procedure for lipolysis that produces less swelling and quicker healing times.

The Smartlipo system is intended for use in laser-assisted lipolysis, a procedure that disrupts fat cells and causes coagulation of the tissue, leading to skin tightening. More...
Clinical trials suggest that patients experience rapid healing with little tissue trauma. Post-operative results can be seen as soon as one week, with continued improvement over several months.

The system uses a small cannula, approximately 1.0-2.0 mm in diameter containing a laser fiber that is inserted percutaneously. The cannula is moved back and forth, delivering the laser's energy to the fat cells, causing them to rupture and easily drain away. The laser energy also interacts with the dermis, resulting in collagen shrinkage. Treatments with the system generally result in less swelling and bleeding and can usually be performed in one 45-minute session. The system had been cleared by the U.S. Food and Drug Administration (FDA).

"I believe that the Smartlipo system is particularly useful for treating areas with localized fat deposits. In addition to disrupting fat, it coagulates and tightens tissue,” said Bruce Katz, M.D., a clinical professor at Mount Sinai School of Medicine (New York, NY, USA) and medical director of JUVA Skin and Laser Center (New York, NY, USA). "We have seen excellent results with this new laser lipolysis procedure.”

The Smartlipo system was developed by Cynosure (Westford, MA, USA).

Nearly 500,000 liposuction procedures were performed in the United States alone in 2005, making it the number one surgical cosmetic procedure among both women and men there, according to the American Society for Aesthetic Plastic Surgery (ASAPS).



Related Links:
Mount Sinai School of Medicine
Cynosure

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.